Annotated Medicine and Device Lists

Hyoscine hydrobromide

Injection 400 mcg/mL Injection 600 mcg/mL Injection 20 mg/mL Injection 0.02 g + 2.5 g dipyrone in 5mL Solution (eye drops) 0.1% Suppository 10 mg Suppository 20 mg Tablet 10 mg Tablet 20 mg Transdermal patches 1 mg/72 hours

This medicine is present in:

List	Section	Observation
Training CSamouge 2022	2.3 Medicines for other common symptoms in palliative care	Others observations: Requires specialist diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training for their use in children
WHO Model List of Essential Medicines (2021)	2.3. Medicines for other common symptoms in palliative care	This medicine is only for children.

This medicine is present in:

List	Section	Observation
Training CSamouge 2022	2.3 Medicines for other common symptoms in palliative care	Others observations: Requires specialist diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training for their use in children
WHO Model List of Essential Medicines (2021)	2.3. Medicines for other common symptoms in palliative care	This medicine is only for children.

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Peru	17.4 Anti-Spasmodics	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	06.3 Anti-Spasmodics	No observations
Training CSamouge 2022	2.3 Medicines for other common symptoms in palliative care	No observations

This medicine is present in:

List	Section	Observation
Colombia	06.3 Anti-Spasmodics	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Peru	17.4 Anti-Spasmodics	No observations
Colombia	06.3 Anti-Spasmodics	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Training CSamouge 2022	2.3 Medicines for other common symptoms in palliative care	Others observations: Requires specialist diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training for their use in children
WHO Model List of Essential Medicines (2021)	2.3. Medicines for other common symptoms in palliative care	This medicine is only for children.

Information Resources: Hyoscine hydrobromide

No information available